Q/C Technologies, Inc. Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss
Q/C Technologies, Inc. (QCLS) reported Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss of $19.46 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments · last filed 2026-08-12
- Q/C Technologies, Inc. marketable securities, gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2026-06-30 was $19.46K.
- Q/C Technologies, Inc. marketable securities, gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2026-03-31 was -$11.78K.
- Q/C Technologies, Inc. marketable securities, gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2025-06-30 was $0.00.
- Q/C Technologies, Inc. marketable securities, gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2025-03-31 was -$2.18K.
- Q/C Technologies, Inc. marketable securities, gain (loss), excluding other-than-temporary impairment loss for fiscal 2025 was -$2.18K.
- Q/C Technologies, Inc. marketable securities, gain (loss), excluding other-than-temporary impairment loss for fiscal 2024 was -$976.00.
- Q/C Technologies, Inc. marketable securities, gain (loss), excluding other-than-temporary impairment loss for fiscal 2023 was -$416.00.
| Period end | Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss 3 month | Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss 6 month | Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss 9 month | Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.46K 10-Q · filed 2026-08-12 | $31.24K 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | -$11.78K 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | -$2.18K 10-K · filed 2026-04-15 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-12 | $2.18K 10-Q · filed 2026-08-12 | -$3.80K derived: sum of 3 quarters · filed 2026-08-12 | -$4.35K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$2.18K 10-Q · filed 2026-05-15 | -$3.80K derived: sum of 2 quarters · filed 2026-05-15 | -$4.35K derived: sum of 3 quarters · filed 2026-05-15 | -$4.43K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$1.63K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$2.18K derived: sum of 2 quarters · filed 2026-04-15 | -$2.25K derived: sum of 3 quarters · filed 2026-04-15 | -$976.00 10-K · filed 2026-04-15 |
| 2024-09-30 | -$551.00 10-Q · filed 2024-11-14 | -$626.00 derived: sum of 2 quarters · filed 2025-08-19 | $651.00 10-Q · filed 2024-11-14 | -$503.00 derived: sum of 4 quarters · filed 2025-08-19 |
| 2024-06-30 | -$75.00 10-Q · filed 2025-08-19 | $100.00 10-Q · filed 2025-08-19 | $48.00 derived: sum of 3 quarters · filed 2025-08-19 | -$452.00 derived: sum of 4 quarters · filed 2025-08-19 |
| 2024-03-31 | -$175.00 10-Q · filed 2025-05-15 | $123.00 derived: sum of 2 quarters · filed 2025-05-15 | -$377.00 derived: sum of 3 quarters · filed 2025-05-15 | -$766.00 derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $298.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-11 | -$202.00 derived: sum of 2 quarters · filed 2025-04-11 | -$591.00 derived: sum of 3 quarters · filed 2025-04-11 | -$416.00 10-K · filed 2025-04-11 |
| 2023-09-30 | -$500.00 10-Q · filed 2024-11-14 | -$889.00 derived: sum of 2 quarters · filed 2024-11-14 | -$714.00 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$389.00 10-Q · filed 2024-08-19 | -$214.00 10-Q · filed 2024-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |